Global Tumor Ablation Market By Technology (Radiofrequency Ablation, Microwave Ablation, , and Other Ablation Technologies), By Treatment (Surgical Ablation, Laparoscopic Ablation, and Percutaneous Ablation), By Application (Kidney Cancer, Liver Cancer, Breast Cancer, and Other Cancers), and by Region and Companies Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2022-2032.
- Published date: Nov 2021
- Report ID: 21174
- Number of Pages: 285
- Format:
- keyboard_arrow_up
- 1. Tumor Ablation Market Introduction
- 1.1. Definition
- 1.2. Taxonomy
- 1.3. Research Scope
- 2. Executive Summary
- 2.1. Key Findings by Major Segments
- 2.2. Top strategies by Major Players
- 3. Global Tumor Ablation Market Overview
- 3.1. Tumor Ablation Market Dynamics
- 3.1.1. Drivers
- 3.1.2. Opportunities
- 3.1.3. Restraints
- 3.1.4. Challenges
- 3.2. PESTLE Analysis
- 3.3. Opportunity Map Analysis
- 3.4. PORTER'S Five Forces Analysis
- 3.5. Market Competition Scenario Analysis
- 3.6. Product Life Cycle Analysis
- 3.7. Opportunity Orbits
- 3.8. Manufacturer Intensity Map
- 3.1. Tumor Ablation Market Dynamics
- 4. Global Tumor Ablation Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028
- 4.1. Global Tumor Ablation Market Analysis by Type: Introduction
- 4.2. Market Size and Forecast by Region
- 4.3. Radiofrequency (RF) Ablation
- 4.4. Microwave Ablation
- 4.5. Cryoablation
- 4.6. Technologies
- 5. Global Tumor Ablation Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
- 5.1. Global Tumor Ablation Market Analysis by Application: Introduction
- 5.2. Market Size and Forecast by Region
- 5.3. Liver Cancer
- 5.4. Lung Cancer
- 5.5. Kidney Cancer
- 6. Global Tumor Ablation Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
- 6.1. North America
- 6.1.1. North America Tumor Ablation Market: Regional Trend Analysis
- 6.1.1.1. US
- 6.1.1.2. Canada
- 6.1.1.3. Mexico
- 6.1.1. North America Tumor Ablation Market: Regional Trend Analysis
- 6.2. Europe
- 6.2.1. Europe Tumor Ablation Market: Regional Trend Analysis
- 6.2.1.1. Germany
- 6.2.1.2. France
- 6.2.1.3. UK
- 6.2.1.4. Russia
- 6.2.1.5. Italy
- 6.2.1.6. Rest of Europe
- 6.2.1. Europe Tumor Ablation Market: Regional Trend Analysis
- 6.3. Asia-Pacific
- 6.3.1. Asia-Pacific Tumor Ablation Market: Regional Trend Analysis
- 6.3.1.1. China
- 6.3.1.2. Japan
- 6.3.1.3. Korea
- 6.3.1.4. India
- 6.3.1.5. Rest of Asia
- 6.3.1. Asia-Pacific Tumor Ablation Market: Regional Trend Analysis
- 6.4. Latin America
- 6.4.1. Latin America Tumor Ablation Market: Regional Trend Analysis
- 6.4.1.1. Brazil
- 6.4.1.2. Argentina
- 6.4.1.3. Rest of Latin America
- 6.4.1. Latin America Tumor Ablation Market: Regional Trend Analysis
- 6.5. Middle East and Africa
- 6.5.1. Middle East and Africa Tumor Ablation Market: Regional Trend Analysis
- 6.5.1.1. GCC
- 6.5.1.2. South Africa
- 6.5.1.3. Israel
- 6.5.1.4. Rest of MEA
- 6.5.1. Middle East and Africa Tumor Ablation Market: Regional Trend Analysis
- 6.1. North America
- 7. Global Tumor Ablation Market Competitive Landscape, Market Share Analysis, and Company Profiles
- 7.1. Market Share Analysis
- 7.2. Company Profiles
- 7.3. Angiodynamics
- 7.3.1. Company Overview
- 7.3.2. Financial Highlights
- 7.3.3. Product Portfolio
- 7.3.4. SWOT Analysis
- 7.3.5. Key Strategies and Developments
- 7.4. Medtronic
- 7.4.1. Company Overview
- 7.4.2. Financial Highlights
- 7.4.3. Product Portfolio
- 7.4.4. SWOT Analysis
- 7.4.5. Key Strategies and Developments
- 7.5. Boston Scientific
- 7.5.1. Company Overview
- 7.5.2. Financial Highlights
- 7.5.3. Product Portfolio
- 7.5.4. SWOT Analysis
- 7.5.5. Key Strategies and Developments
- 7.6. Galil Medical
- 7.6.1. Company Overview
- 7.6.2. Financial Highlights
- 7.6.3. Product Portfolio
- 7.6.4. SWOT Analysis
- 7.6.5. Key Strategies and Developments
- 7.7. Neuwave Medical
- 7.7.1. Company Overview
- 7.7.2. Financial Highlights
- 7.7.3. Product Portfolio
- 7.7.4. SWOT Analysis
- 7.7.5. Key Strategies and Developments
- 7.8. Misonix
- 7.8.1. Company Overview
- 7.8.2. Financial Highlights
- 7.8.3. Product Portfolio
- 7.8.4. SWOT Analysis
- 7.8.5. Key Strategies and Developments
- 7.9. Merit Medical
- 7.9.1. Company Overview
- 7.9.2. Financial Highlights
- 7.9.3. Product Portfolio
- 7.9.4. SWOT Analysis
- 7.9.5. Key Strategies and Developments
- 7.10. Sonacare Medical
- 7.10.1. Company Overview
- 7.10.2. Financial Highlights
- 7.10.3. Product Portfolio
- 7.10.4. SWOT Analysis
- 7.10.5. Key Strategies and Developments
- 7.11. EDAP TMS
- 7.11.1. Company Overview
- 7.11.2. Financial Highlights
- 7.11.3. Product Portfolio
- 7.11.4. SWOT Analysis
- 7.11.5. Key Strategies and Developments
- 8. Assumptions and Acronyms
- 9. Research Methodology
- 10. Contact
- 1. Tumor Ablation Market Introduction
- Angiodynamics (Covidien)
- Boston Scientific Corporation
- Medtronic Plc
- Ethicon, Inc.
- Galil Medical Inc.
- Misonix Inc.
- HealthTronics
- Mermaid Medical
- Theraclion
- Chongqing Haifu Medical Technology Co. Ltd.
- HS Hospital Service S.P.A
- EDAP TMS S.A.
- Other Key Players
- settingsSettings
Our Clients
- 21174
- Nov 2021
-
US $5,999US $2,999
-
US $7,999US $3,499
-
US $12,999US $4,499
✖
Request a Sample Report
We'll get back to you as quickly as possible|
Single User
$5,999
$2,999
USD / per unit
save 50% |
Multi User
$7,999
$3,499
USD / per unit
save 55% |
Corporate User
$12,999
$4,499
USD / per unit
save 65% | |
|---|---|---|---|
| e-Access | |||
| Data Set (Excel) | |||
| Company Profile Library Access | |||
| Interactive Dashboard | |||
| Free Custumization | No | up to 10 hrs work | up to 30 hrs work |
| Accessibility | 1 User | 2-5 User | Unlimited |
| Analyst Support | up to 20 hrs | up to 40 hrs | up to 50 hrs |
| Benefit | Up to 20% off on next purchase | Up to 25% off on next purchase | Up to 30% off on next purchase |
| Buy Now ($ 2,999) | Buy Now ($ 3,499) | Buy Now ($ 4,499) |
